Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer

Author: Chan JK

Prognostic and predictive blood-based biomarkers (BMs) in patients (pts) with advanced epithelial ovariancancer (EOC) treated with carboplatinpaclitaxel (CP) ± bevacizumab (BEV)